Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Inositol for PCOS and infertility: a large review finds the evidence still thin

☕ Includes a question for the family ↓

InositolPart of a story we are following · 1 article · See every update
Assorted dried beans and lentils in a close-up showing many colors and shapes.
Assorted dried beans and lentils in a close-up showing many colors and shapes.Photo: Bean appreciator / Wikimedia Commons, CC0

If you have heard that inositol might help with PCOS and getting pregnant, here is where the science stands today: not settled. The answer is not a clear yes or no, and that is useful to know before you spend money or plan around it.

In a Cochrane review of 21 studies with 1,634 women who had PCOS and infertility, the evidence on myo-inositol (the type tested) was too weak to say clearly whether it helps women have a baby. One small result pointed in a hopeful direction for women doing IVF, but it was rated low certainty.

How the study worked

This is a review that pools earlier randomized trials, where women are assigned by chance to a treatment or a comparison. It was published on November 18, 2026 in the Cochrane Database of Systematic Reviews. The authors searched medical databases up to November 10, 2025, and the main limit is that the trials were small and few of them could be combined, so many answers stay open.

What is inositol, and why do women with PCOS take it?

Inositol is a dietary supplement that is widely available. Women with polycystic ovary syndrome (PCOS) commonly use it. PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in May 2026, so you may see both names.

The idea behind it is that inositol may affect how the body responds to insulin and how the ovaries work. In practice, doctors often prescribe myo-inositol to women with PCOS who are having ovulation induction or intrauterine insemination (IUI), or who are getting ready for in vitro fertilization (IVF).

What they found

The review included 21 studies with 1,634 women with PCOS who were trying to become pregnant. Sixteen of those studies were new since the last version of the review. The trials took place in Iran, India, Italy, Albania, Germany and Vietnam. All the women got usual preconception care. Every trial with usable data tested myo-inositol, so the review says nothing firm about other forms.

The authors rated the overall certainty of the evidence as low or very low. In plain words, the results could change a lot if better studies came along.

Women having IVF. Three studies with 164 women compared myo-inositol with no treatment. Women who took it may have been slightly more likely to get pregnant. That is the most encouraging result in the review, but it is only low-certainty evidence. For live birth and miscarriage, two studies with 84 women were too small to tell. For multiple pregnancy, the one trial that looked at it had no cases in either group.

Women having ovulation induction or IUI. Only one study, with 120 women, looked at this. Women who took myo-inositol had more live births in that trial. But with just one small study, the authors say they are unsure whether it truly makes a difference.

Myo-inositol versus metformin in IVF. Metformin is another medicine that helps the body use insulin. One study with 102 women compared the two. Again, the evidence was very low certainty, so the authors could not say which does better.

Safety. The review also looked at miscarriage, multiple pregnancy and a complication called ovarian hyperstimulation syndrome. The studies were too small to show whether myo-inositol raises or lowers any of these. Some outcomes, such as gestational diabetes, were not reported in several comparisons.

What does “low certainty” mean?

It means the researchers do not have much confidence that the result would hold up in a bigger, better trial. A hopeful number in a small study is a reason to study something further. It is not proof that it works.

What you can do today

Write down what you take, and what treatment you are on (ovulation induction, IUI or IVF). Bring both to your next fertility appointment and ask your doctor whether myo-inositol makes sense for your plan, since the research differs by treatment.

For clinicians and researchers

Design: Cochrane systematic review and meta-analysis of RCTs of oral inositol in women with PCOS and infertility: 21 studies, 1634 women, from Iran, India, Italy, Albania, Germany and Vietnam. Comparators were placebo, no treatment or metformin; searches ran to 10 November 2025.

Main result: Myo-inositol vs no treatment before IVF may slightly raise clinical pregnancy (3 studies, 164 women; low certainty). Live birth was uncertain (2 studies, 84 women; very low certainty).

Main limitation: Certainty of evidence was low to very low, downgraded for indirectness and imprecision. Most comparisons rest on one or two small studies, and all eligible data concerned myo-inositol only.

Open question: Larger, well-conducted RCTs are needed to establish effects on live birth and adverse events, including in ovulation induction/intrauterine insemination, and against other insulin-sensitising agents. D-chiro-inositol also lacks eligible outcome data.

Talk about it at home

Scientists gathered many small studies about a supplement and put their results together, a bit like asking lots of neighbors about a restaurant instead of trusting a single friend. In those studies, women were assigned by chance to take it or not, so the two groups could be compared fairly. Even after pooling them, the studies were so small that the scientists could not say for sure what the supplement does.

Question for the table

Imagine a class wants to find out whether a new kind of sneaker makes kids run faster. Why would it help to have some kids wear the new sneakers and others wear their usual ones, and why should a coin toss decide who gets which?

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Inositol for PCOS and infertility: a large review finds the evidence still thin. Mongevity. Published November 19, 2026. Accessed November 22, 2026. https://mongevity.science/metabolism/2026/11/inositol-pcos-infertility-evidence-review/
Vancouver
Mongevity Desk. Inositol for PCOS and infertility: a large review finds the evidence still thin [Internet]. Mongevity; 2026 Nov 19 cited 2026 Nov 22]. Available from: https://mongevity.science/metabolism/2026/11/inositol-pcos-infertility-evidence-review/
APA
Mongevity Desk. (2026, November 19). Inositol for PCOS and infertility: a large review finds the evidence still thin. Mongevity. https://mongevity.science/metabolism/2026/11/inositol-pcos-infertility-evidence-review/
For your website
<a href="https://mongevity.science/metabolism/2026/11/inositol-pcos-infertility-evidence-review/">Inositol for PCOS and infertility: a large review finds the evidence still thin</a>

Free to share or quote with credit and a link.

Questions and answers

Does inositol help women with PCOS get pregnant?
The review could not say for sure. The evidence was low or very low certainty, and the trials were small. One result hinted at a slight rise in pregnancy for women doing IVF.
Which type of inositol was studied?
All trials with usable data tested myo-inositol. The review has no firm findings on other forms, such as D-chiro-inositol.
Did the review find that inositol is harmful?
It could not tell. The studies were too small to show whether myo-inositol raises or lowers the chance of miscarriage, multiple pregnancy or ovarian hyperstimulation.
Is PCOS now called something else?
Yes. PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in May 2026, so you may see both names.

Sources

  1. Cochrane Database Syst Rev: Inositol for infertile women with polycystic ovary syndrome (PMID 43049177 · DOI 10.1002/14651858.cd012378.pub3) · 2026-11-19
Report an error